A population antibody response against SARS-CoV-2 with differential neutralization activities towards the Delta and Omicron variants

Xiaoli Xiong(Henan University of Technology), Ling Chen(Guangzhou Institutes of Biomedicine and Health), Andrew P. Carter(MRC Laboratory of Molecular Biology), Kun Qu(Singapore General Hospital), Jizheng Chen(Guangzhou Institutes of Biomedicine and Health), Jun He(Hunan Normal University), Jincun Zhao(ShanghaiTech University), John A. G. Briggs(MRC Laboratory of Molecular Biology), Pingchao Li(Chinese Academy of Sciences), Hao Sun(Fudan University), Haisu Yi(First Affiliated Hospital of Guangzhou Medical University), Xijie Gao(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Banghui Liu(Chinese Academy of Sciences), Peiyu Hu(Chinese Academy of Sciences), Jing Sun(First Affiliated Hospital of Guangzhou Medical University), Bo Feng(Ruijin Hospital), Qiuluan Chen(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Xiaolin Zhong(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Xinwen Chen(Guangzhou Experimental Station), Rongjuan Pei(Chinese Academy of Sciences), Qihong Yan(First Affiliated Hospital of Guangzhou Medical University), Xiaofeng Liu, Qian Wang(Army Medical University), Yanjun Zhang(Shanxi Medical University), Ping He(Shihezi University), Jinsong Liu(Guangzhou Institutes of Biomedicine and Health), Zhilong Chen(Xiamen University), Jin Liang(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Zimu Li(Chinese Academy of Sciences), Ruitian Hou(Chinese Academy of Sciences), Xuefeng Niu(First Affiliated Hospital of Guangzhou Medical University), Katarzyna A. Ciazynska
Research Square
March 14, 2022
Cited by 1


Related Papers